These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19430207)
1. Cancer cell death by design: apoptosis, autophagy and glioma virotherapy. Tyler MA; Ulasov IV; Lesniak MS Autophagy; 2009 Aug; 5(6):856-7. PubMed ID: 19430207 [TBL] [Abstract][Full Text] [Related]
2. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. Ulasov IV; Sonabend AM; Nandi S; Khramtsov A; Han Y; Lesniak MS Br J Cancer; 2009 Apr; 100(7):1154-64. PubMed ID: 19277041 [TBL] [Abstract][Full Text] [Related]
3. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. Ulasov IV; Tyler MA; Zhu ZB; Han Y; He TC; Lesniak MS Int J Oncol; 2009 Mar; 34(3):729-42. PubMed ID: 19212678 [TBL] [Abstract][Full Text] [Related]
4. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993 [TBL] [Abstract][Full Text] [Related]
5. Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX. Kaverina NV; Kadagidze ZG; Borovjagin AV; Karseladze AI; Kim CK; Lesniak MS; Miska J; Zhang P; Baryshnikova MA; Xiao T; Ornelles D; Cobbs C; Khramtsov A; Ulasov IV Oncogene; 2018 Nov; 37(46):6069-6082. PubMed ID: 29991800 [TBL] [Abstract][Full Text] [Related]
6. An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment. Kostova Y; Mantwill K; Holm PS; Anton M Cancer Gene Ther; 2015 Jan; 22(1):30-43. PubMed ID: 25501992 [TBL] [Abstract][Full Text] [Related]
7. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo. Gomez-Gutierrez JG; Nitz J; Sharma R; Wechman SL; Riedinger E; Martinez-Jaramillo E; Sam Zhou H; McMasters KM Virology; 2016 Jan; 487():249-59. PubMed ID: 26561948 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model. Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507 [TBL] [Abstract][Full Text] [Related]